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A 60-year-old white man presented an ulcerated and bleeding swelling in the upper
lip. The right hard and soft palate showed a swelling covered by a yellowish mem-
brane. Microscopical examination showed a monotonous diffuse lymphoid prolifera-
tion of large cells with plasmablastic differentiation. The cells were immunopositive
for VS38c. A PCR demonstrated IgH with monoclonal pattern and EBV DNA. The
lesions resolved after treatment with local radiotherapy and systemic chemother-
apy. The patient remains free of the disease after twenty-three months of treat-









Diffuse large B-cell lymphoma (DLBCL) is the most
common type of lymphoma in western countries,
representing about one third of these neoplasm.1741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
oi:10.1016/j.ooe.2005.02.008
* Corresponding author. Tel.: +55 31 3499 2478; fax: +55 31
499 2472.
E-mail address: ramesquita@ufmg.br (R.A. Mesquita).The diversity of clinical presentations, genetic,
and molecular characteristics suggests that these
neoplasm represent a heterogeneous group. How-
ever, the World Health Organization (WHO, 2001)
considers the DLBCL as a specific category.10
Plasmablastic lymphoma (PBL) was initially de-
scribed as a rare variant of DLBCL. It’s present in
people infected by the human immunodeficiency
virus (HIV).5 PBL has predilection for the oral cavityrved.
Figure 1 (A) Clinical appearance of the plasmablastic lymphoma of oral mucosa type show asymmetric face. (B)
Intraoral view demonstrates an ulcerated and bleeding swelling in the upper lip. The right hard and soft palate showed
a swelling covered by a yellowish membrane. (C) Computed tomography scan demonstrate a lesion infiltrating the
parapharyngeal space, nasal fossae and right maxillary sinus. (D) Microscopic appearance of monotonous diffuse
lymphoid proliferation composed by large cells with plasmablastic differentiation (hematoxylin-eosin, original
magnification ·200). (E) Lymphoid neoplastic cells immunopositive for VS38C (streptavidin-biotin technique, original
magnification ·200). (F) 2.0% agarose gel eletrophoresis after PCR amplification of DNA. Track 1 is negative control.
Track 2 is DNA from tonsil. Track 3 is DNA from plasmablastic lymphoma of oral mucosa type with a discrete and
homogeneity band (approximately 110 bases pare). Track 4 is DNA from plasmablastic lymphoma of oral mucosa type
with presence of the EBV genome (band of 269 bases pares) (PCR technique, original size). (G) Clinical appearance of
face after fifteen months of treatment. (H) Computed tomography scan after fifteen months of treatment within
evidence of the lesion.
122 E.C. Barroso Duarte et al.with local invasion and rapid dissemination to
extraoral sites. PBL have a poor prognosis with
average survival time of the six months.5,13,7 In
addition, it exhibited an immunophenotypic profile
with absent or weak expression of B-cell markersand reactivity for plasma cell associated antigens,
and is EBV-positive.4
We reported the clinical, microscopical,
immunohistochemical, molecular features, EBV
research and management of PBL of oral mucosa
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patient.Case report
A 60-year-old white man was referred to the Oral
Medicine of Odilon Behrens Hospital for investiga-
tion of a swelling in the face. Extraoral examina-
tion demonstrated asymmetric face (Fig. 1(A)).
Intraoral examination revealed an ulcerated and
bleeding swelling in the upper lip. The right hard
and soft palate showed a swelling covered by a yel-
lowish membrane (Fig. 1(B)). A craniofacial com-
puted tomography scan demonstrated a presence
of lesion infiltrating the parapharyngeal space,
nasal fossae and right maxillary sinus (Fig. 1(C)).
An incisional biopsy was performed, and the speci-
men fixed in 10% neutral formalin solution.
Section 5 lm thick was stained with hematoxy-
lin-eosin. Microscopical examination showed a
monotonous diffuse lymphoid proliferation com-
posed by large cells. The cells presented with oval
to round, vesicular nuclei with fine chromatin, 2–4
membrane bound nucleoli (centroblasts) or single
centrally located nucleolus (immunoblasts). Cells
with plasmablastic differentiation were observed.
A ‘‘starry sky’’ with apoptotic bodies and macro-
phages was present (Fig. 1(D)). Sections 3 lm thick
were submitted for immunohistochemical evalua-
tion by the streptavidin-biotin protocol. Appropri-
ated positive and negative controls were
included. The malignant cells were immunopositive
for VS38c (Dako Corporation, Carpinteria, CA, USA;
clone M7077; dilution 1:50), immunonegative for
CD20 (Dako Corporation, Carpinteria, CA, USA;
clone L26; dilution 1:50), CD3 (Dako Corporation,
Carpinteria, CA, USA; Clone M0835; dilution 1:50),
and cytokeratin AE1/AE3 (Dako Corporation, Car-
pinteria, CA, USA; clone M3515; dilution 1:50)
(Fig. 1(E)). Antigen retrieval was performed with
steam-heat antigen retrieval (30 min citric
acid—10 mmol/L, pH 6.0).
Extraction of the genomic DNA was performed
from the paraffin block in accordance with proto-
cols described by Isola et al.9 and Mesquita et al.11
The heavy immunoglobulin gene rearrangement
(IgH) analysis was performed by a semi-nested
polymerase chain reaction (PCR). The primers
used have been previously described by Trainor
et al.14 and Wan et al.16 PCR amplified DNA was
electrophoresed in 2.0% agarose and visualized un-
der ultraviolet light after ethidium bromide stain-
ing. A negative control was used for all PCR
reactions. Tonsil was used as control for polyclo-
nality. The DNA obtained of the case showed a dis-crete and homogenous band on electrophoresis
(Fig. 1(F)). The Epstein–Barr virus (EBV) genome
was demonstrated by PCR. The primers used in
PCR have previously described by Ammatuna
et al.2 Appropriate negative controls and positive
controls were performed. The DNA obtained of
the case showed a 269pb band on electrophoresis
(Fig. 1(F)). The diagnosis PBL of oral mucosa type
was made.
The patient was HIV-negative by three ELISA-
tests. The patient was treated with 6 cycles of
cyclophosphamide (120 mg), adriamycin (80 mg),
oncoxin (2 mg) and prednisone (100 mg), and
twenty-three sections of radiotherapy with
360 cGy/day. The lesions resolved and the patient
remains free disease after fifteen months (Fig.
1(G) and (H)).Discussion
Clinical, microscopical, immunohistochemical,
molecular and EBV research findings observed in
present case qualifies for the diagnosis of PBL of
oral mucosa type. This lymphoma show oral
mucosa involvement, plasma cell immunopheno-
typic profile, EBV infection, and frequent associa-
tion with HIV-positive patient. The IgH analysis
confirms the profile of B-cells in this lymphoma
type.8 Eight cases of PBL of oral mucosa type in
HIV negative patients were described by Delecluse
et al.5; Oyama, et al.12; Colomo et al.4 The patient
presented is HIV negative.
Colomo et al.4 identified several subgroups of
DLBCL with plasmablastic features: PBL of oral mu-
cosa type, PBL with plasmablastic differentiation,
extramedullary plasmablastic tumors secondary to
plasma cell neoplasm, and other large cell lympho-
mas with plasmablastic differentiation.
The treatment of non-Hodgkin lymphomas de-
pends of the staging and includes radiotherapy,
chemotherapy, and surgery or combination of
these modalities.15 The high remission rate cur-
rently is observed with combined radiochemiother-
apy.6,3 In our case the patient was treated with a
combination of chemotherapy and radiotherapy
and the patient remains clinically stable after this
treatment.Acknowledgement
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